These examples underscore the pivotal role of BiP/GRP78 in conferring resistance to chemotherapeutic and immune-targeted drugs, with targeting BiP/GRP78 emerging as a promising strategy for enhancing cancer treatment. Here, HSPA5 is linked to cancer.